RadNet (RDNT) Stock: Buy, Sell, or Hold?

RDNT - RadNet, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$69.65
0.38 (0.55%) ▲
5d: -2.6%
30d: -4.16%
90d: +17.61%
BUY
MODERATE Confidence
Analysis Updated: Oct 20, 2026 12:00 AM ET
Earnings: Nov 09, 2026 18d

Get Alerted When RDNT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: RDNT shows positive signals but monitor for confirmation. Market pricing in 1.8% growth. Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$43.17
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$26.80
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: RDNT is currently trading at $69.65, which is considered slightly low relative to its 30-day fair value range of $68.89 to $74.50. The stock's valuation (Forward PE: 78.5) is in line with its historical norms (74.4). At these levels, the market is pricing in 1.8% annual earnings growth.

Technical Outlook: Technically, RDNT is in a strong uptrend. Immediate support is located at $66.23, while resistance sits at $72.15.

Market Sentiment: RDNT scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $94.62 (+35.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $68.89 - $74.50
Company Quality Score 63/100 (BUY)
Volume Confirmation HIGH
Confidence Score 95.0%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (64/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 35.9% below Wall St target ($94.62)
  • BULLISH: Expecting earnings turnaround to 1.8% growth with 25.0% revenue growth
  • BULLISH: Bottoming setup score 64/100 — corrected, stabilizing, and turning up

Trading Range Analysis

30-Day Trading Range $68.89 - $74.50
Current vs Trading Range SLIGHTLY LOW
Expected Move (7 Days) ±$5.58 (8.0%)

Support & Resistance Levels

Support Level $66.23
Resistance Level $72.15
Current Trend Strong Uptrend
Technical data as of Oct 20, 2026

Fundamental Context

Forward P/E (Next Year Est.) 78.55
Wall Street Target $94.63 (+35.9%)
Revenue Growth (YoY) 25.0%
Earnings Growth (YoY) -49.1%
Profit Margin -0.9%
Valuation Premium vs History +1.8% premium
PE vs Historical 78.6 vs 74.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.8% (market-implied from PE analysis)
1-Year Target $70.90 (+2%)
2-Year Target $72.18 (+4%)
3-Year Target $73.48 (+6%)
3-Yr Target (if PE normalizes) (PE: 79→74) PE COMPRESSION $69.60 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 78.5, Growth: 72.4%) $235.07 (+238%)
Base: (SPY PE: 19.9, Growth: 72.4%) $59.43 (-15%)
Bear: (PE: 16.9, Growth: 72.4%) $50.52 (-28%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 20, 2026 8:34 PM ET
Data refreshes hourly during market hours. Next update: 9:34 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RDNT.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
GH
Guardant Health Inc
STRONG BUY
26 analysts
$202 59 HOLD
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 52 HOLD
TMO
Thermo Fisher Scientific…
STRONG BUY
28 analysts
$691 44 HOLD
NTRA
Natera Inc
STRONG BUY
23 analysts
$404 53 HOLD
DHR
Danaher Corporation
STRONG BUY
25 analysts
$244 46 HOLD

Advanced RDNT Option Strategies

Professional options setups generated by AI based on today's RDNT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for RDNT

RDNT Technical Chart RDNT Price Prediction RDNT Earnings Date RDNT Investment Advisor RDNT Fair Price Analyzer RDNT Options Advisor RDNT Options Chain RDNT Options Analysis RDNT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals